T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles

Arthritis and Rheumatism

Volumn 42, Issue 7, 1999, Pages 1497-1507

  Cope, Andrew P ^a,b   Patel, Salil D ^b   Hall, Frances ^b   Congia, Mauro ^b   Hubers, Henk A J M ^c   Verheijden, Gijs F ^c   Boots, Annemieke M H ^c   Menon, Rajasree ^d   Trucco, Massimo ^d   Rijnders, Antonius W M ^c   Sønderstrup, Grete ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NV ORGANON   (Netherlands)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; HLA DR4 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; EPITOPE MAPPING; IMMUNIZATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0033509783     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199907)42:7<1497::aid-anr25>3.0.co;2-%23     Document Type: Article

References (41)

1. Harris EJ. Clinical features of rheumatoid arthritis. In: Kelley W, Harris E, Ruddy S, Sledge C, editors. Textbook of rheumatology. Philadelphia: WB Saunders; 1997. p. 898-932.
2. Deighton CM, Walker DJ, Griffiths ID, Roberts DF. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989;36: 178-82.
3. Nepom GT. Major histocompatibility complex-directed susceptibility to rheumatoid arthritis. Adv Immunol 1998;68:315-32.
4. Gregerson PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30: 1205-13.
5. Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A 1989;86:10049-53.
6. Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, et al. HLA genes associated with rheumatoid arthritis: identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 1989;32:15-21.
7. Ollier W, Thomson W. Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am 1992;18:741-59.
8. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
9. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994;368:215-21.
10. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996;384:134-41.
11. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, et al. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 1995;181: 1847-55.
12. Friede T, Gnau V, Jung G, Keilholz W, Stevanovic S, Rammensee HG. Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides. Biochim Biophys Acta 1996;1316:85-101.
13. Fu X, Bono CP, Woulfe SL, Swearingen C, Summers NL, Sinigaglia F, et al. Pocket 4 of the HLA-DR(αβ1*0401) molecule is a major determinant of T cell recognition of peptide. J Exp Med 1995;181:915-26.
14. Penzotti JE, Doherty D, Lybrand TP, Nepom GT. A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. J Autoimmun 1996;9:287-93.
15. Penzotti JE, Nepom GT, Lybrand TP. Use of T cell receptor/ HLA-DRB1*04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis. Arthritis Rheum 1997;40:1316-26.
16. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 1997;7: 473-81.
17. Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jacob CO, et al. A molecular basis for MHC class II-associated autoimmunity. Science 1988;240:1003-9.
18. Wucherpfennig KW, Strominger JL. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune disease. J Exp Med 1995;181:1597-601.
19. Verheijden GFM, Rijnders AWM, Bos E, Coenen-de Roo CJJ, van Staveren CJ, Miltenburg AMM, et al. Human cartilage glycoprotein-39 is a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997;40:1115-25.
20. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-10.
21. Hu B, Trinh K, Figueira WF, Price PA. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 1996;271: 19415-20.
22. Morrison BW, Leder P. Neu and ras initiate murine inflammatory tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 1994;9:3417-26.
23. Nyirkos P, Golds EE. Human synovial cells secrete a 39 kDa protein similar to bovine mammary protein expressed during the non-lactating period. Biochem J 1990;268:265-8.
24. Johansen JS, Jensen HS, Price PA. A new biochemical marker for joint injury: analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 1993;32:949-55.
25. Fugger L, Michie SA, Rulifson I, Lock CB, Sønderstrup-McDevitt G. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region β-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci U S A 1994;91:6151-5.
26. Killeen N, Sawada S, Littman D. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J 1993;12:1547-53.
27. Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, et al. Mice lacking MHC class II molecules. Cell 1991;66:1051-66.
28. Patel SD, Cope AP, Congia M, Chen TT, Kim E, Fugger L, et al. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 using HLA-DR(α1*0101, β1*0401) transgenic mice. Proc Natl Acad Sci U S A 1997;94: 8082-7.
29. k transgene. Proc Natl Acad Sci U S A 1990;87:7319-23.
30. Fugger L, Rothbard JB, Sønderstrup-McDevitt G. Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen. Eur J Immunol 1996;26:928-33.
31. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
32. Faas SJ, Menon R, Braun ER, Rudert WA, Trucco M. Sequence-specific priming and exonuclease-released fluorescence detection of HLA-DQB1 alleles. Tissue Antigens 1996;48:97-112.
33. Congia M, Patel SD, Cope AP, De Virgiliis S, Sønderstrup G. The T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from the pro-hormones preproinsulin and proinsulin. Proc Natl Acad Sci U S A 1998;95:3833-8.
34. Marsh SG, Bodmer JG. HLA class II region nucleotide sequences. Tissue Antigens 1995;46:258-80.
35. Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AE, Burgdorfer W, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983;308:733-40.
36. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994;56:389-466.
37. Bikoff EK, Germain RN, Robertson EJ. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 1995;2:301-10.
38. Sloan VS, Cameron P, Porter G, Gammon G, Amaya M, Mellins E, et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995;375:802-6.
39. Viner NJ, Nelson CA, Deck B, Unanue ER. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J Immunol 1996;156:2365-8.
40. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995;181:1569-74.
41. Hosken NA, Shibuya K, Heath AW, Murphy KM, O'Garra A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 1995;182:1579-84.